Cyclic helix B peptide ameliorates renal tubulointerstitial fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway

BACKGROUND: Renal fibrosis is the inevitable outcome of all progressive chronic kidney diseases (CKD) and leads to a gradual loss of renal function. We previously reported cyclic helix B peptide (CHBP), a novel synthesized peptide derived from erythropoietin, had shown effective renoprotection. In t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Qi, Ruochen, Zhang, Weitao, Zheng, Long, Xu, Ming, Rong, Ruiming, Zhu, Tongyu, Yang, Cheng
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154394/
https://ncbi.nlm.nih.gov/pubmed/32309314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars